Gaining Insight into SARS-CoV-2 Infection and COVID-19 Severity Using
Self-supervised Edge Features and Graph Neural Networks
- URL: http://arxiv.org/abs/2006.12971v2
- Date: Tue, 15 Dec 2020 17:05:18 GMT
- Title: Gaining Insight into SARS-CoV-2 Infection and COVID-19 Severity Using
Self-supervised Edge Features and Graph Neural Networks
- Authors: Arijit Sehanobish, Neal G. Ravindra, David van Dijk
- Abstract summary: We seek to use deep learning to study the biology of SARS-CoV-2 infection and COVID-19 severity.
We propose a model that builds on Graph Attention Networks (GAT), creates edge features using self-supervised learning, and ingests these edge features via a Set Transformer.
We apply our model to single-cell RNA sequencing datasets of SARS-CoV-2 infected lung organoids and bronchoalveolar lavage fluid samples of patients with COVID-19.
- Score: 8.980876474818153
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: A molecular and cellular understanding of how SARS-CoV-2 variably infects and
causes severe COVID-19 remains a bottleneck in developing interventions to end
the pandemic. We sought to use deep learning to study the biology of SARS-CoV-2
infection and COVID-19 severity by identifying transcriptomic patterns and cell
types associated with SARS-CoV-2 infection and COVID-19 severity. To do this,
we developed a new approach to generating self-supervised edge features. We
propose a model that builds on Graph Attention Networks (GAT), creates edge
features using self-supervised learning, and ingests these edge features via a
Set Transformer. This model achieves significant improvements in predicting the
disease state of individual cells, given their transcriptome. We apply our
model to single-cell RNA sequencing datasets of SARS-CoV-2 infected lung
organoids and bronchoalveolar lavage fluid samples of patients with COVID-19,
achieving state-of-the-art performance on both datasets with our model. We then
borrow from the field of explainable AI (XAI) to identify the features (genes)
and cell types that discriminate bystander vs. infected cells across time and
moderate vs. severe COVID-19 disease. To the best of our knowledge, this
represents the first application of deep learning to identifying the molecular
and cellular determinants of SARS-CoV-2 infection and COVID-19 severity using
single-cell omics data.
Related papers
- Bayesian Networks and Machine Learning for COVID-19 Severity Explanation and Demographic Symptom Classification [12.40025057417184]
We present a three-stage data-driven approach to distill the hidden information about COVID-19.
The first stage employs a Bayesian network structure learning method to identify the causal relationships among COVID-19 symptoms.
As a second stage, the output serves as a useful guide to train an unsupervised machine learning (ML) algorithm.
The final stage then leverages the labels obtained from clustering to train a demographic symptom identification model.
arXiv Detail & Related papers (2024-06-16T05:43:24Z) - CoVScreen: Pitfalls and recommendations for screening COVID-19 using Chest X-rays [1.0878040851637998]
The novel coronavirus (COVID-19), a highly infectious respiratory disease caused by the SARS-CoV-2 has emerged as an unprecedented healthcare crisis.
Early screening and diagnosis of symptomatic patients plays crucial role in isolation of patient to help stop community transmission.
Due to its accessibility, availability, lower-cost, ease of sanitisation, and portable setup, chest X-Ray imaging can serve as an effective screening and diagnostic tool.
arXiv Detail & Related papers (2024-05-13T12:03:15Z) - COVID-Net Biochem: An Explainability-driven Framework to Building
Machine Learning Models for Predicting Survival and Kidney Injury of COVID-19
Patients from Clinical and Biochemistry Data [66.43957431843324]
We introduce COVID-Net Biochem, a versatile and explainable framework for constructing machine learning models.
We apply this framework to predict COVID-19 patient survival and the likelihood of developing Acute Kidney Injury during hospitalization.
arXiv Detail & Related papers (2022-04-24T07:38:37Z) - DEEMD: Drug Efficacy Estimation against SARS-CoV-2 based on cell
Morphology with Deep multiple instance learning [8.716655008588361]
Drug repurposing can accelerate the identification of effective compounds for clinical use against SARS-CoV-2.
DEEMD is a computational pipeline using deep neural network models within a multiple instance learning framework.
DEEMD identifies known SARS-CoV-2 inhibitors, such as Remdesivir and Aloxistatin, supporting the validity of our approach.
arXiv Detail & Related papers (2021-05-10T20:38:34Z) - COVID-Net CT-S: 3D Convolutional Neural Network Architectures for
COVID-19 Severity Assessment using Chest CT Images [85.00197722241262]
We introduce COVID-Net CT-S, a suite of deep convolutional neural networks for predicting lung disease severity due to COVID-19 infection.
A 3D residual architecture design is leveraged to learn volumetric visual indicators characterizing the degree of COVID-19 lung disease severity.
arXiv Detail & Related papers (2021-05-04T04:44:41Z) - COVIDx-US -- An open-access benchmark dataset of ultrasound imaging data
for AI-driven COVID-19 analytics [116.6248556979572]
COVIDx-US is an open-access benchmark dataset of COVID-19 related ultrasound imaging data.
It consists of 93 lung ultrasound videos and 10,774 processed images of patients infected with SARS-CoV-2 pneumonia, non-SARS-CoV-2 pneumonia, as well as healthy control cases.
arXiv Detail & Related papers (2021-03-18T03:31:33Z) - COVID-FACT: A Fully-Automated Capsule Network-based Framework for
Identification of COVID-19 Cases from Chest CT scans [29.327290778950324]
We propose a two-stage fully-automated framework for identification of COVID-19 positive cases referred to as the "COVID-FACT"
COVID-FACT detects slices with infection, and identifies positive COVID-19 cases using an in-house CT scan dataset.
Based on our experiments, COVID-FACT achieves an accuracy of 90.82%, a sensitivity of 94.55%, a specificity of 86.04%, and an Area Under the Curve (AUC) of 0.98, while depending on far less supervision and annotation.
arXiv Detail & Related papers (2020-10-30T03:30:22Z) - Semi-supervised Neural Networks solve an inverse problem for modeling
Covid-19 spread [61.9008166652035]
We study the spread of COVID-19 using a semi-supervised neural network.
We assume a passive part of the population remains isolated from the virus dynamics.
arXiv Detail & Related papers (2020-10-10T19:33:53Z) - Deep Learning Models for Early Detection and Prediction of the spread of
Novel Coronavirus (COVID-19) [4.213555705835109]
SARS-CoV2 is continuing to spread globally and has become a pandemic.
There is an urgent need to develop machine learning techniques to predict the spread of COVID-19.
arXiv Detail & Related papers (2020-07-29T10:14:11Z) - Understanding the temporal evolution of COVID-19 research through
machine learning and natural language processing [66.63200823918429]
The outbreak of the novel coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been continuously affecting human lives and communities around the world.
We used multiple data sources, i.e., PubMed and ArXiv, and built several machine learning models to characterize the landscape of current COVID-19 research.
Our findings confirm the types of research available in PubMed and ArXiv differ significantly, with the former exhibiting greater diversity in terms of COVID-19 related issues.
arXiv Detail & Related papers (2020-07-22T18:02:39Z) - COVID-DA: Deep Domain Adaptation from Typical Pneumonia to COVID-19 [92.4955073477381]
The outbreak of novel coronavirus disease 2019 (COVID-19) has already infected millions of people and is still rapidly spreading all over the globe.
Deep learning has been used recently as effective computer-aided means to improve diagnostic efficiency.
We propose a new deep domain adaptation method for COVID-19 diagnosis, namely COVID-DA.
arXiv Detail & Related papers (2020-04-30T03:13:40Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.